Por: Los Angeles Times Science January 28, 2023
The Food and Drug Administration has withdrawn its provisional support for the use of Evusheld, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19. With new viral variants increasingly adept at defeating Evusheld, the FDA said the biological drug should no longer be used. The FDA decision marks the end — at least for now — of a medication that had helped... + full article
ABC News USA Health December 20, 2022
WASHINGTON -- The lack of clear direction and priorities at the U.S. Food and Drug Administration's tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
Panel warns FDA’s beleaguered tobacco unit lacks direction | Associated Press
Panel warns FDA’s beleaguered tobacco unit lacks direction | WPLG Local 10
Associated Press USA Politics December 19, 2022
WASHINGTON (AP) — The lack of clear direction and priorities at the U.S. Food and Drug Administration’s tobacco division has hampered its ability to regulate electronic cigarettes and other products, according to an expert panel assembled to examine problems at the agency.A... + más
Panel warns FDA’s beleaguered tobacco unit lacks direction | ABC News
Fox Business USA Business December 02, 2022
Fox News medical contributor Dr. Marty Makary discusses the 'unique set' of long COVID symptoms and explains why it's not likely to become the next public health disaster on 'Varney & Co.' The Food and Drug Administration announced on Wednesday that is... + más
Twitter was once a necessity for major brands. Under Elon Musk, it's now high risk. | CBS News
FDA pauses authorization for last remaining COVID-19 monoclonal antibody treatment | The Hill
New York Daily News USA Health October 10, 2022
Kids, prep those arms. Moderna announced Wednesday that it’s ready to ask the Food and Drug Administration for emergency authorization to begin administering the COVID-19 vaccine to children under 6 years old after testing a lower-dosage shot on about 6,700 participants. Two... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
WPLG Local 10 USA Politics September 30, 2022
WASHINGTON – A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration approved... + más
ALS drug wins FDA approval despite questionable data | ABC News
Associated Press USA Science September 30, 2022
WASHINGTON (AP) — A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.The Food and Drug Administration... + más
About iurex | Privacy Policy | Disclaimer |